Efficacy and safety of disodium ascorbyl phytostanol phosphates in men with moderate dyslipidemia

OBJECTIVE: This study investigated the efficacy, safety, tolerability, and pharmacokinetics of a novel cholesterol absorption inhibitor, FM-VP4, comprising disodium ascorbyl sitostanol phosphate (DASP) and disodium ascorbyl campestanol phosphate (DACP). METHODS: In phase 1, 30 men received a single...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Vissers, Maud N., Trip, Mieke D., Pritchard, P. Haydn, Tam, Patrick, Lukic, Tatjana, de Sain-van der Velden, Monique G., de Barse, Martina, Kastelein, John J. P.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer-Verlag 2008
Aiheet:
Clinical Trial
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2426926/
https://ncbi.nlm.nih.gov/pubmed/18320185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-008-0462-1
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia